We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Project Initiated for Advancement of New Biomedical Imaging Technology

By LabMedica International staff writers
Posted on 18 Oct 2010
A new project aims to develop a new generation of smart, complementary metal-oxide-semiconductor (CMOS)-based large area networked image sensors for photon-starved biomedical applications.

SPADnet, a Fully Networked, Digital Components for Photon-starved Biomedical Imaging Systems, is a new collaborative research project funded by the European Union within the Information and Communication Technologies (ICT; Brussels, Belgiumt) theme of its Seventh Research Framework Program (FP7). More...
The project launched on July 1, 2010, is coordinated by the Ecole Polytechnique Federale Lausanne (EPFL; Switzerland) and it includes seven leading European experts in image sensors, medical imaging, and photonics. SPADnet was granted 3.7 million EUR of funding over a 42-month period. The SPADnet consortium met on July 16, 2010 in Budapest, Hungary, for its general kick-off meeting.

SPADnet's goal is to build ring-assembly modules for positron emission tomography (PET) imaging, and carry out performance tests in a PET evaluation system. While suited to applications offering repetitive measurement techniques, existing sensors are not well adapted to single-shot, rare events often occurring in diagnostic tools based on specific radiation detection, PET, single photon emission computed tomography (SPECT), gamma cameras, and other minimally invasive point of care tools. Moreover, the comparatively small field-of-view of existing sensors is a limiting factor.

SPADnet's prime objective is to develop a scalable photonic component for large format, rare-event imaging. The core of the component will be a SPAD (single photon avalanche diode) array implemented in CMOS. Large formats will be achieved by tessellating several tens of dies in abutment style using innovative packaging techniques based on through-silicon vias (TSVs). The ability to stamp the time and position of each photon impingement in a burst event offers a second key advance. The concept of spatial oversampling is introduced, where a single measurement is partitioned into a myriad of submeasurements, occurring simultaneously. The difference is that in space oversampling many SPADs will detect the same event independently, thus reducing the dead time on average by the number of detectors involved. The decomposition of the large format imager to a network of independent arrays is key to managing massive data streams. In conventional photomultiplier tubes (PMTs) or silicon photomultipliers (SiPMs), the sensitive device produces a stream of analogue electrical pulses, whereas the photonic component proposed in this project will generate streams of precomputed digital data.

The current state-of-the-art on inter-chip data exchange will be the basis for efficient data communication, in a true network communication style. Data packets will be routed in the network and will be handled on-demand. For example, coincidence-mapping engines can be used in this context as snoopers on the data bus, thus considerably simplifying systems such as PET.

Related Links:

European Union within the Information and Communication Technologies




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.